Kolon Life Science Inc. (KOSDAQ:102940)

Kolon Life Science Revenue

Kolon Life Science had revenue of 49.66B KRW in the quarter ending March 31, 2026, with 10.76% growth. This brings the company's revenue in the last twelve months to 213.81B, up 27.52% year-over-year. In the year 2025, Kolon Life Science had annual revenue of 208.98B with 29.49% growth.

• Revenue (ttm): 213.81B
• Revenue Growth: +27.52%
• P/S Ratio: 3.08
• Revenue / Employee: 503.07M
• Employees: 425
• Market Cap: 658.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	208.98B	47.59B	29.49%
Dec 31, 2024	161.39B	36.75B	29.48%
Dec 31, 2023	124.64B	-36.94B	-22.86%
Dec 31, 2022	161.58B	-3.90B	-2.36%
Dec 31, 2021	165.49B	36.07B	27.87%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error